scorecardresearch
Add as a preferred source on Google
Wednesday, December 3, 2025
TopicPfizer

Topic: Pfizer

Expert panel seeks additional data on Covid vaccines from Serum Institute, Bharat Biotech

The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.

After HCQ, India pushes vaccine diplomacy in S. Asia as China rushes in with its Covid shots

As Beijing offers its own Sinovac-made vaccine to Pakistan, Sri Lanka, Nepal and Bangladesh, India takes steps to have a locally-made vaccine distributed to friendly nations.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

Pfizer Covid shot is highly effective, has no safety concerns, US FDA staff report says

The report offers a first look at the US review of the vaccine ahead of a public meeting Thursday of outside advisers to the agency.

90-year-old Ireland woman becomes first patient to receive Pfizer Covid vaccine

Margaret Keenan became the first person in the world to receive the Pfizer Covid vaccine outside trial conditions after it got the green light in the UK last week.

Govt begins internal review of Pfizer and Serum Covid vaccines, focus on safety & quality

The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.

Pricing of Pfizer’s Covid vaccine will depend on advance booking & doses ordered, says firm

Pfizer has become the first pharmaceutical firm to seek emergency use for its Covid-19 vaccine from the Drugs Controller General of India.

Pfizer seeks emergency use approval of its Covid BioNTech vaccine in India

After the nod from UK and Bahrain, the firm has sought permission to import the vaccine for sale and distribution besides waiver on clinical trials in India.

BioNTech founder Ugur Sahin joins world’s 500 richest after UK approves Covid vaccine

BioNTech’s shares have jumped almost 8% this week and are up more than 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion.

Pfizer, BioNTech seek regulatory clearance from EU for Covid vaccine

BioNTech Chief Financial Officer said the company can start shipping the first doses 'within hours' after regulatory clearance.

On Camera

Indian bureaucracy doesn’t need DOGE. Hiring more would be better for efficiency

The view that bureaucracies are bloated with far too many employees preying on taxpayers money is a widely held myth. Research shows how significantly understaffed the Indian state is.

India’s Insolvency & Bankruptcy Code is struggling to deliver. It’ll take a decade to clear backlog

The Centre is considering an increase in the National Company Law Tribunal's bench capacity, while the Standing Committee of Finance suggests fast-track courts. 

India to commission new squadron of submarine-hunting Romeo choppers in Goa later this month

The helicopters produced by Lockheed Martin are known as ‘submarine hunters’. India ordered 24 of these aircraft in 2020 to replace the Sea King helicopters. 15 have been delivered till date.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.